The pulmonary macrophage in acute leukemia

Nov 11, 2011·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Kazunori NakaseNaoyuki Katayama

The development and function of lung-resident macrophages and dendritic cells

Dec 19, 2014·Nature Immunology·Manfred KopfSamuel P Nobs

Macrophages and Cardiovascular Health

Aug 30, 2018·Physiological Reviews·Vanessa Frodermann, Matthias Nahrendorf

Isolation and characterization of fibroblasts obtained by pulmonary lavage of human subjects.

Aug 1, 1979·In Vitro·G S DavisG M Green

Cell kinetics of pulmonary alveolar macrophages in the mouse

Mar 1, 1982·Cell and Tissue Kinetics·J E Coggle, J D Tarling

Evidence for the pulmonary origin of alveolar macrophages

Nov 1, 1982·Cell and Tissue Kinetics·J D Tarling, J E Coggle

Origin and ontogeny of lung macrophages: from mice to humans.

Nov 13, 2019·Immunology·Elza EvrenTim Willinger

Endotoxin-induced colony stimulating activity in normal and myeloid leukaemic subjects.

Mar 1, 1979·Scandinavian Journal of Haematology·W HinterbergerK Mittermayer

Age-dependent resistance of human alveolar macrophages to herpes simplex virus.

May 1, 1980·Infection and Immunity·L MintzT N Finley

Interaction of alveolar macrophages with Nocardia asteroides: immunological enhancement of phagocytosis, phagosome-lysosome fusion, and microbicidal activity.

Nov 1, 1980·Infection and Immunity·C Davis-Scibienski, B L Beaman

Dynamics of the phagocytic cell response within the lungs of parabiotic mice infected with mycobacteria with decreasing virulence for mice.

Jul 1, 1990·Infection and Immunity·F M Collins

Macrophage progenitor cell and colony-stimulating factor production during granulomatous schistosomiasis mansoni in mice.

Oct 1, 1988·Infection and Immunity·C R ClarkD L Boros

Direct evidence for a bone marrow origin of the alveolar macrophage in man

Jun 4, 1976·Science·E D ThomasD W Golde

❮ Previous

Next ❯

Related Concepts

Related Feeds

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

The pulmonary macrophage in acute leukemia

Abstract

References

Regulation of granulopoiesis: positive feed-back

Production of colony-stimulating factor by human macrophages

The origin of alveolar macrophages in mouse radiation chimeras

Letter: Growth of pulmonary alveolar macrophages in vitro

Proliferative capacity of human alveolar macrophage

The structure and function of monocytes and macrophages

The human alveolar macrophage: isolation, cultivation in vitro, and studies of morphologic and functional characteristics

Low yield of pulmonary surfactant in cigarette smokers

Human blood monocytes: stimulators of granulocyte and mononuclear colony formation in vitro

Identification of the colony-stimulating cell in human peripheral blood

Citations

Isolation of human splenic macrophages and lymphocytes by countercurrent centrifugal elutriation

Metabolism of testosterone to 17 beta-hydroxy-5 alpha-androstane-3-one and 5 alpha-androstane-3 alpha, 17 beta-diol in alveolar macrophages from rat lung

Metabolism of testosterone to 17 beta-hydroxy-5 alpha-androstane-3-one and 5 alpha-androstane-3 alpha, 17 beta-diol in alveolar macrophages from rat lung--II. Effects of intratracheal instillation of 3.4 mumol K2Cr2O7

Drug-induced lipidosis and the alveolar macrophage

Regulation of granulopoiesis

The pulmonary-alveolar macrophage (first of two parts)

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40-1993. A 61-year-old woman with jaundice, anemia, thrombocytopenia, and leukocytosis

Update on macrophage clearance of inhaled micro- and nanoparticles

Pulmonary host defenses

Beyond stem cells: self-renewal of differentiated macrophages

Occult pulmonary haemorrhage in leukaemia

Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages

Oxidant injury of lung parenchymal cells

Proliferation activity and bacteriostatic potential of human blood monocytes, macrophages in pleural effusions, ascites, and of alveolar macrophages

Human lung tissue as a source of colony stimulating activity.

The alveolar macrophage

The effects of asbestos on macrophages

Dose response of the pulmonary macrophagic system to various particulates and its relationship to transepithelial passage of free particles

Macrophages, dust, and pulmonary diseases

Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review

Desquamative interstitial pneumonitis associated with monomyelocytic leukemia

Endotoxin-induced myeloid reactions in dogs

Acute interstitial pneumonitis during chemotherapy for haematological malignancy

Tissue macrophage identity and self-renewal

Alveolar macrophage dysfunction in human bone marrow transplant recipients

Respiratory infections may reflect deficiencies in host defense mechanisms

Respiratory tract infections: intrinsic risk factors

Pathogenesis of fever of unknown origin in patients with acute leukemia and granulocytopenia

Monocyte migration across pulmonary membranes in mice infected with cytomegalovirus.

The detection of two surface antigens on human lung macrophages using monoclonal antibodies

Is elevation of the serum β-d-glucan level a paradoxical sign for trichosporon fungemia in patients with hematologic disorders?